Literature DB >> 10337920

Site-specific control of T cell traffic in the brain: T cell entry to brainstem vs. hippocampus after local injection of IFN-gamma.

L M Phillips1, L A Lampson.   

Abstract

Although it is known that neurotransmitters and neuropeptides can affect immune function in vitro, less is understood about how the neural environment affects immune function in the brain. Previously, we showed that regulation of parenchymal class II MHC after local injection of IFN-gamma is site-specific. In this companion study, we defined the effect of local IFN-gamma on the entry of class II-restricted T cells to the brain parenchyma. To activate endogenous T cells, adult CDF rats were immunized with a normal neural antigen (MBP). Two weeks later, the proinflammatory cytokine IFN-gamma (100 to 10,000 U/site) was injected stereotaxically into two neurochemically and anatomically distinct sites, the hippocampus (area CAI) and brainstem (nucleus of the solitary tract). Monoclonal R73 was used to detect T cells on cryostat sections. The greatest difference was seen 48 h after 300 U IFN-gamma was injected at each site, when there were several-fold more parenchymal T cells in the brainstem than in the hippocampus. Most parenchymal T cells were CD4+ /class II-restricted. Thus, parenchymal T cell entry and parenchymal class II up-regulation show the same hierarchy (brainstem >> hippocampus) after local IFN-gamma injection, although T cell entry was more sensitive to the IFN-gamma dose. We suggest that the local regulatory environment contributes to site-specific immune regulation, and discuss implications for the distribution of MS plaques and other aspects of local immune control. Further, in interpreting the many previous studies of cytokine-mediated immune changes in the CNS, the possibility of site-specific differences should be considered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337920     DOI: 10.1016/s0165-5728(99)00034-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  New animal models to probe brain tumor biology, therapy, and immunotherapy: advantages and remaining concerns.

Authors:  L A Lampson
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

Review 2.  Cytokine networks in glioma.

Authors:  Kenichiro Iwami; Atsushi Natsume; Toshihiko Wakabayashi
Journal:  Neurosurg Rev       Date:  2011-06-09       Impact factor: 3.042

3.  Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs.

Authors:  Iryna A Isakova; Jason Dufour; Calvin Lanclos; Julie Bruhn; Donald G Phinney
Journal:  Exp Hematol       Date:  2010-07-01       Impact factor: 3.084

4.  Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis.

Authors:  Martin Kerschensteiner; Christine Stadelmann; Bigna S Buddeberg; Doron Merkler; Florence M Bareyre; Daniel C Anthony; Christopher Linington; Wolfgang Brück; Martin E Schwab
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

5.  VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis.

Authors:  Sébastien Serres; Silvy Mardiguian; Sandra J Campbell; Martina A McAteer; Asim Akhtar; Alexandre Krapitchev; Robin P Choudhury; Daniel C Anthony; Nicola R Sibson
Journal:  FASEB J       Date:  2011-09-09       Impact factor: 5.191

6.  Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences.

Authors:  Adam D Hart; Andreas Wyttenbach; V Hugh Perry; Jessica L Teeling
Journal:  Brain Behav Immun       Date:  2011-12-02       Impact factor: 7.217

7.  Neuroprotection by IFN-γ via astrocyte-secreted IL-6 in acute neuroinflammation.

Authors:  Lijie Sun; Yan Li; Xiuzhi Jia; Qi Wang; Yue Li; Minghui Hu; Linlu Tian; Jinfeng Yang; Wenjing Xing; Weihua Zhang; Jingtao Wang; Hongwei Xu; Lihua Wang; Dekai Zhang; Huan Ren
Journal:  Oncotarget       Date:  2017-06-20

8.  Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis.

Authors:  Jason R Lees; Paul T Golumbek; Julia Sim; Denise Dorsey; John H Russell
Journal:  J Exp Med       Date:  2008-10-13       Impact factor: 14.307

9.  Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration.

Authors:  Ikuo Tsunoda; Tomoko Tanaka; Yukio Saijoh; Robert S Fujinami
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.